Category: pharma & healthcare

On the one-year anniversary of the IRA’s signing, most of the bill’s impact on drug prices and Medicare beneficiary out-of-pocket spending has yet to be determined.

Researchers at the University of Pennsylvania investigated a new, potentially less toxic method that corrects the pathogenic genes at their source.

Researchers at the University of Pennsylvania investigated a new, potentially less toxic method that corrects the pathogenic genes at their source.

Studies suggest that pairing rehabilitative motor therapy with vagus nerve stimulation may help individuals regain lost skills.

In a groundbreaking development, gene therapy delivered through eyedrops has restored the sight of a teenager who has been legally blind for most of his life.

This story is part of a series on the current A new brain-computer interface decoder enables researchers to construct continuous language using only MRI brain scans.

As part of a three-part series, this installment will explore how mRNA could replace toxic chemotherapy and radiation procedures.

This article will explore if omega-3s can help treat eye diseases and take a critical look at the potential of omega-3s, offering a glimpse into the future of eye care.

A comprehensive review by the University of Nevada investigated dry age-related macular degeneration and the latest investigational therapeutics for treating the disease.

In the coming years, a new in-ear bioelectronic called SpiralE may be the next step toward seamless brain-computer interfaces.